As shown in Figure 3B, while the expression level of the β-actin, which was used as the internal control, was comparable, the expression level of most of the tested tumor antigens was significantly up-regulated upon DAC treatment in AML cells except K562 cells, which barely responded to the DAC treatment. The gene discussed is ACTB; the disease is neoplasm.